Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings

Diabetes Research and Clinical Practice

Volumn 74, Issue 3, 2006, Pages 301-308

  Cugati, Sudha ^a   Kifley, Annette ^a   Mitchell, Paul ^a   Wang, Jie Jin ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Blue Mountains Eye Study; Diabetes; Diabetic retinopathy; Population based; Prevalence

Indexed keywords

GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; POPULATION; PREVALENCE; RETINA;

AGED; AGED, 80 AND OVER; AGING; AUSTRALIA; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; TIME FACTORS;

EID: 33750215774     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.04.002     Document Type: Article

References (49)

1. Amos A.F., McCarty D.J., and Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year. Diabet. Med. (1997) S1-S85
2. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diab. Care 9 (1998) 1414-1431
3. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab. Care 5 (2004) 1047-1053
4. Jonsson B. The economic impact of diabetes. Diab. Care (1998) C7-C10
5. American Academy of Ophthalmology, Preferred Practice Pattern: Diabetic Retinopathy, American Academy of Ophthalmology, 2003.
6. Kempen J.H., O'Colmain B.J., Leske M.C., Haffner S.M., Klein R., Moss S.E., et al. The prevalence of diabetic retinopathy among adults in the United States. Arch. Ophthalmol. 4 (2004) 552-563
7. Caro J.J., Ward A.J., and O'Brien J.A. Lifetime costs of complications resulting from type 2 diabetes in the US. Diab. Care 3 (2002) 476-481
8. World Medical Association, Declaration of Helsinki: ethical principals for research involving human subjects. www.wma.net/e/ethicsunit/helsinki.htm, 2004 (9-3-2006).
9. Mitchell P., Smith W., Attebo K., and Wang J.J. Prevalence of age-related maculopathy in Australia. The blue mountains eye study. Ophthalmology 10 (1995) 1450-1460
10. Mitchell P., Smith W., Wang J.J., and Attebo K. Prevalence of diabetic retinopathy in an older community. The blue mountains eye study. Ophthalmology 3 (1998) 406-411
11. Foran S., Wang J.J., and Mitchell P. Causes of visual impairment in two older population cross-sections: the blue mountains eye study. Ophthalmic Epidemiol. 4 (2003) 215-225
12. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus, World Health Organization, 1999.
13. Early Treatment Diabetic Retinopathy Study Research Group, Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs-An Extension of the Modified Airlie House classification (Report No. 10), Ophthalmology (1991) 786-806.
14. Early Treatment Diabetic Retinopathy Study Research Group, Fundus Photographic Risk Factors for Progression of Diabetic Retinopathy, ETDRS Report Number 12, Ophthalmology (1991) 823-833.
15. Attebo K., Mitchell P., and Smith W. Visual acuity and the causes of visual loss in Australia. The blue mountains eye study. Ophthalmology 3 (1996) 357-364
16. Foran S., Mitchell P., and Wang J.J. Five-year change in visual acuity and incidence of visual impairment: the blue mountains eye study. Ophthalmology 1 (2003) 41-50
17. Dunstan D.W., Zimmet P.Z., Welborn T.A., De Court, Cameron A.J., Sicree R.A., et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diab. Care 5 (2002) 829-834
18. Ramachandran A., Snehalatha C., Latha E., Vijay V., and Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia 2 (1997) 232-237
19. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The third national health and nutrition examination survey, 1988-1994. Diab. Care 4 (1998) 518-524
20. Drivsholm T., Ibsen H., Schroll M., Davidsen M., and Borch-Johnsen K. Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old danes. Diabet. Med. 2 (2001) 126-132
21. Laakso M., Reunanen A., Klaukka T., Aromaa A., Maatela J., and Pyorala K. Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987. Am. J. Epidemiol. 9 (1991) 850-857
22. Leibson C.L., O'Brien P.C., Atkinson E., Palumbo P.J., and Melton L.J. Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: a population-based study. Am. J. Epidemiol. 1 (1997) 12-22
23. Midthjell K., Kruger O., Holmen J., Tverdal A., Claudi T., Bjorndal A., et al. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The nord-trondelag health surveys: 1984-1986 and 1995-1997. Diab. Care 11 (1999) 1813-1820
24. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA 1 (2003) 76-79
25. Australian Bureau of Statistics (Ed.), Special article-Long-term mortality trends, Year Book Australia 2002, Commonwealth of Australia, Canberra, Australia, 2002 (1301.0-2002).
26. Bi P., Parton K.A., and Donald K. Secular trends in mortality rates for diabetes in Australia, 1907-1998. Diabetes Res. Clin. Pract. 3 (2005) 270-277
27. Golay A., and Ybarra J. Link between obesity and type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 4 (2005) 649-663
28. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 14 (2002) 1723-1727
29. Cameron A.J., Welborn T.A., Zimmet P.Z., Dunstan D.W., Owen N., Salmon J., et al. Overweight and obesity in Australia: the 1999-2000 Australian diabetes, obesity and lifestyle study (AusDiab). Med. J. Aust. 9 (2003) 427-432
30. Chua B., Rochtchina E., and Mitchell P. Temporal changes in the control of blood pressure in an older Australian population. J. Hum. Hypertens. 9 (2005) 691-696
31. McKay R., McCarty C.A., and Taylor H.R. Diabetic retinopathy in Victoria, Australia: the visual impairment project. Br. J. Ophthalmol. 8 (2000) 865-870
32. McCarty D.J., Fu C.L., Harper C.A., Taylor H.R., and McCarty C.A. Five-year incidence of diabetic retinopathy in the Melbourne visual impairment project. Clin. Exp. Ophthalmol. 5 (2003) 397-402
33. Tapp R.J., Shaw J.E., Harper C.A., De Court, Balkau B., McCarty D.J., et al. The Prevalence of and factors associated with diabetic retinopathy in the Australian population. Diab. Care 6 (2003) 1731-1737
34. Younis N., Broadbent D.M., Vora J.P., and Harding S.P. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool diabetic eye study: a cohort study. Lancet 9353 (2003) 195-200
35. Moss S.E., Klein R., and Klein B.E. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 6 (1994) 1061-1070
36. Stratton I.M., Kohner E.M., Aldington S.J., Turner R.C., Holman R.R., Manley S.E., et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2 (2001) 156-163
37. Mitchell P. Development and progression of diabetic eye disease in Newcastle 1977-1984: rates and risk factors. Aust. N. Z. J. Ophthalmol. (1985) 39-44
38. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial, Diabetes 8 (1995) 968-983.
39. Harris M.F., Priddin D., Ruscoe W., Infante F.A., and O'Toole B.I. Quality of care provided by general practitioners using or not using division-based diabetes registers. Med. J. Aust. 5 (2002) 250-252
40. Kamien M., Ward A.M., Mansfield F., Fatovich B., Mather C., and Anstey K. Management of type 2 diabetes in western Australian metropolitan general practice. Diabetes Res. Clin. Pract. 3 (1994) 197-208
41. Backlund L.B., Algvere P.V., and Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet. Med. 9 (1997) 732-740
42. Vinding T. Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. Copenh. (1990) 162-167
43. Porta M., Tomalino M.G., Santoro F., Ghigo L.D., Cairo M., Aimone M., et al. Diabetic retinopathy as a cause of blindness in the province of Turin, north-west Italy, in 1967-1991. Diabet. Med. 4 (1995) 355-361
44. Brown J.B., Pedula K.L., and Summers K.H. Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diab. Care 9 (2003) 2637-2642
45. N. Jaross, P. Ryan, H. Newland, Prevalence of diabetic retinopathy in an aboriginal Australian population: results from the katherine region diabetic retinopathy study (KRDRS), Report no. 1, Clin. Exp. Ophthalmol. 1 (2003) 32-39.
46. Australian Institute of Health & Welfare (AIHW). Commonwealth Department of Health and Ageing, Diabetes Mellitus. First Report on National Health Priority Areas 1996 (1997), Australian Institute of Health & Welfare (AIHW), Canberra pp. 143-151
47. Management of Diabetic Retinopathy, Clinical Practice Guidelines, Canberra, Commonwealth Department of Health and Family Services, 1997, pp. 1-94.
48. Glasgow R.E. Translating research to practice: lessons learned, areas for improvement, and future directions. Diab. Care 8 (2003) 2451-2456
49. Thomas R.J., Palumbo P.J., Melton III L.J., Roger V.L., Ransom J., O'Brien P.C., et al. Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch. Intern. Med. 4 (2003) 445-451